The persistent exclusion of older patients from ongoing clinical trials regarding heart failure.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Internal Medicine

• Publication date

  2011-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archinternmed.2011.31PMID 21444844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease

  2009cited by this paper
• Clinical trial participation: are we studying the patients we are trying to treat?

  2009cited by this paper
• Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin IIReceptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?

  2009cited by this paper
• Irbesartan in patients with heart failure and preserved ejection fraction.

  2008cited by this paper
• Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.

  2007cited by this paper
• Eligibility criteria of randomized controlled trials.

  2007cited by this paper
• How to Get Older People Included in Clinical Studies

  2007cited by this paper
• Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

  2005cited by this paper
• The causes and effects of socio-demographic exclusions from clinical trials.

  2005cited by this paper
• Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

  2005cited by this paper
• The Burden of Chronic Congestive Heart Failure in Older Persons: Magnitude and Implications for Policy and Research

  2004cited by this paper
• Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.

  2003influential reference
• Patients with chronic heart failure encountered in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials.

  2003cited by this paper
• Age discrimination in trials and treatment: Old dogs and new tricks

  2003cited by this paper
• Hospitalization rates and length of stay for cardiovascular conditions in Canada, 1994 to 1999.

  2003cited by this paper
• Representation of the elderly, women, and minorities in heart failure clinical trials.

  2002influential reference
• Selection of Patients may Limit the Generalizability of Results from Cancer Trials

  2002cited by this paper
• Reporting the Recruitment Process in Clinical Trials: Who Are These Patients and How Did They Get There?

  2002cited by this paper
• Reporting the Recruitment Process in Clinical Trials: Who Are These Patients and How Did They Get There?

  2002cited by this paper
• Spectrum of heart failure in older patients: results from the National Heart Failure project.

  2002cited by this paper
• Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.

  2000cited by this paper
• Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study

  2000cited by this paper
• Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

  1999cited by this paper
• CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults

  1997influential reference
• Representation of older patients in cancer treatment trials.

  1994cited by this paper
• Representation of older patients in cancer treatment trials

  1994cited by this paper
• The exclusion of the elderly and women from clinical trials in acute myocardial infarction.

  1992cited by this paper

• Implementation of guideline-directed medical treatment for ischemic heart disease management: A knowledge, attitude and practice based cross-sectional survey

  2026cites this paper
• Advancing the methodology of clinical trials for aging populations: A call to innovation, inclusion, and global relevance

  2025cites this paper
• Enhancing the methodology of clinical trials in older people: A scoping review with global perspective

  2025cites this paper
• Enrollment of all-female and lactating or pregnant female participants in cardiovascular trials

  2025cites this paper
• Patient Characteristics and Mortality Trends Among Octogenarians With Heart Failure

  2025cites this paper
• From Dialogue to Action: Community Recommendations for Inclusive Research Participation Among Underrepresented Populations

  2025cites this paper
• Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults

  2025cites this paper
• Who participates in randomised controlled trials evaluating physiotherapy interventions for persistent low back pain? A scoping review

  2025cites this paper
• Atrial Fibrillation as a Geriatric Syndrome: Why Are Frailty and Disability Often Confused? A Geriatric Perspective from the New Guidelines

  2025cites this paper
• Clarifying the GDF15-LTL relationship: The role of medications, lifestyle, and morbidity

  2025cites this paper
• Evidence paradox: Enhancing clinical trials for older adults

  2025cites this paper
• Achieving equitable recruitment through inclusive protocol design: lessons learned from the ILANA study

  2025cites this paper
• Effectiveness of Sacubitril/Valsartan in Reducing Hospitalizations in Older Belgian Adults with Heart Failure and Reduced Ejection Fraction: An Age-Stratified Study

  2025cites this paper
• Optimizing Cardiovascular Care in Aging Populations: A Comprehensive Review of Geriatric Cardiology

  2025cites this paper
• There is more than one Frailty Index, and some may not be fit for purpose.

  2025cites this paper
• Perceptions of the Intensity of Heart Failure Medications among Hospitalized Older Adults: A Pilot Qualitative Study

  2025cites this paper
• Impact of Standardized Heart Failure Management Center Construction on the Management of Patients With Chronic Heart Failure

  2025cites this paper
• Heart failure types and predictors of 30-day rehospitalisation among patients aged ≥ 60 years with acute heart failure: a multicentre prospective study in Vietnam

  2025cites this paper
• Adherence to Guideline-Directed Medical Therapy in Hospitalized Older People with Heart Failure at Discharge and 3-Month Follow-Up

  2025cites this paper
• Effectiveness and safety of chronic diuretic use in older adults: an umbrella review of recently published systematic reviews and meta-analyses of randomized-controlled trials

  2025cites this paper
• Medication and Outcome in Older Heart Failure Patients: Results from a Prospective Cohort Study

  2024cites this paper
• Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan

  2024cites this paper
• Prevalence of heart failure pharmacotherapy utilisation, frailty and adverse drug events among hospitalised adults older than 75 years: a multicentre cross‐sectional study

  2024cites this paper
• Aging in Heart Failure: Embracing Biology Over Chronology: JACC Family Series.

  2024cites this paper
• Association Between Clinical Trial Participation Status and Outcomes With Mitral Transcatheter Edge-to-Edge Repair.

  2024cites this paper
• How to make cardiology clinical trials more inclusive

  2024cites this paper
• The effect of down‐titration and discontinuation of heart failure pharmacotherapy in older people: A systematic review and meta‐analysis

  2024cites this paper
• Use and Benefit of Sacubitril/Valsartan in Elderly Patients with Heart Failure with Reduced Ejection Fraction

  2024cites this paper
• Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX‐AHF‐2 trial

  2024cites this paper
• Between Scylla and Charybdis: Navigating heart failure management in complex older adults

  2024cites this paper
• Appropriate management of heart failure in older people with frailty

  2024cites this paper
• YELLOW RoUTIne prospective cohort study protocol: insight in the dynamics of bacteria in the elderly bladder

  2024cites this paper
• Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines

  2024cites this paper
• “Hospice Care Could Be a Compassionate Choice”: ChatGPT Responses to Questions About Decision Making in Advanced Cancer

  2024cites this paper
• Cardiovascular Disease in the Older Adult

  2024cites this paper
• Comparison of explicit criteria for potentially inappropriate drug prescribing among the elderly: a narrative review

  2024cites this paper
• Limiting Factors in Implementing Pharmacovigilance Principles in the Elderly

  2023cites this paper
• Long-Term Outcomes of Early Coronary Artery Disease Testing After New-Onset Heart Failure

  2023cites this paper
• Patient-centric drug product development acceptability across patient populations- Science and evidence.

  2023cites this paper
• The median doses of beta‐blockers among older adults with heart failure with reduced ejection fraction

  2023cites this paper
• Prävalenz, Inzidenz und prädiktive Faktoren von Vorhofflimmern (VHF) bei geriatrischen Patienten – eine prospektive Beobachtungsstudie

  2023cites this paper
• Optimising the care for older persons with complex chronic conditions in home care and nursing homes: design and protocol of I-CARE4OLD, an observational study using real-world data

  2023cites this paper
• More COACHing Needed to Optimize Care after Heart Failure Hospitalization.

  2023cites this paper
• Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism

  2023cites this paper
• Cross-cultural adaptation and its impact on research in emergency care

  2023cites this paper
• Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism

  2023cites this paper
• [Features of pharmacotherapy of vascular cognitive impairment in the elderly].

  2023cites this paper
• Why are older adults living with the complexity of multiple long-term conditions, frailty and a recent deterioration in health under-served by research? A narrative synthesis review of the literature

  2023cites this paper
• The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients

  2023cites this paper
• Conflicting perspectives during guidelines development are an important source of implementation failure.

  2023cites this paper
• Relationship between Pharmacological Treatment Strategy and Cognitive Function in Geriatric Patients with Atrial Fibrillation

  2023cites this paper
• Aging as a Key Player in the Hypertension and Cardiovascular Disorders

  2023cites this paper
• Gaps in Modern Heart Failure and Chronic Kidney Disease Research

  2023cites this paper
• Tools and guidelines to assess the appropriateness of medication and aid deprescribing: An umbrella review

  2023cites this paper
• Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction

  2023cites this paper
• Guideline-Directed Medical Therapies for Heart Failure with a Reduced Ejection Fraction in Older Adults: A Narrative Review on Efficacy, Safety and Timeliness

  2023cites this paper
• Systematic review of research barriers, facilitators, and stakeholders in long-term care and geriatric settings, and a conceptual mapping framework to build research capacity

  2023cites this paper
• Disparities in clinical trial participation in ovarian cancer: A real-world analysis.

  2023cites this paper
• Identification of subgroups within a Japanese older adult population for whom statin therapy is effective in reducing mortality

  2023cites this paper
• Comment on: Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications

  2023cites this paper
• Frailty interferes with the guideline‐directed medical therapy in heart failure patients with reduced ejection fraction

  2022cites this paper
• Sex differences in the impact of frailty in elderly outpatients with heart failure

  2022cites this paper
• Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study

  2022cites this paper
• Tackling the lack of diversity in health research

  2022cites this paper
• Mortality and readmission risk in relation to QRS duration among patients hospitalized for heart failure with preserved ejection fraction.

  2022cites this paper
• The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic Review

  2022cites this paper
• Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients)

  2022cites this paper
• Practical management of frailty in older patients with heart failure

  2022cites this paper
• Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced

  2022cites this paper
• Prognostic impact of neurohormonal modulation in very old patients with chronic heart failure.

  2022cites this paper
• Frailty as a predictor of clinical problems and events that require elderly patients with heart failure to use health resources.

  2022cites this paper
• Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH

  2022cites this paper
• On the perspective of an aging population and its potential impact on drug attrition and pre-clinical cardiovascular safety assessment.

  2022cites this paper
• Consensus expert opinion on key items in planning and designing clinical trials in geriatric patients

  2022cites this paper
• Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist

  2022cites this paper
• Comparative effectiveness of CRT in older patients with heart failure: Systematic review and meta-analysis.

  2021cites this paper
• Exploring the pragmatic-explanatory spectrum across cardiovascular clinical trials.

  2021cites this paper
• Features of pharmacotherapy at elderly and senile patients

  2021cites this paper
• Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement

  2021cites this paper
• Inclusion of People with Disabilities in Research to Improve Medication Adherence: A Systematic Review

  2021cites this paper
• Storage of cryoprecipitate: Role of blood storage

  2021cites this paper
• Upper age limits for convalescent plasma donation and treatment of COVID‐19 patients: A further marker of ageism

  2021cites this paper
• Clinical trials in geriatrics: actual status and international regulatory guidlines

  2021cites this paper
• Association Between Physical Status and the Effects of Combination Therapy With Renin-Angiotensin System Inhibitors and β-Blockers in Patients With Acute Heart Failure

  2021cites this paper
• Heart failure in the elderly

  2021cites this paper
• Доменный подход в ведении пожилых пациентов с сердечной недостаточностью. Настоящее и будущее

  2021cites this paper
• Quality and Safety in the Literature: July 2021

  2021cites this paper
• Patients 80 + have similar medication initiation rates to those aged 50–79 in Ontario FLS

  2021cites this paper
• Increasing representation and diversity in cardiovascular clinical trial populations

  2021cites this paper
• Polypharmacy in Heart Failure: Progress, But Also Problem.

  2021cites this paper
• Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrollment status: A propensity matched analysis.

  2021cites this paper
• Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

  2021cites this paper
• Medication-Use Behavior of Elderly Patients in Baghdad City: A Cross-Sectional Study

  2021cites this paper
• Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review

  2021cites this paper
• Underprescription of medications in older adults: causes, consequences and solutions—a narrative review

  2021cites this paper
• Using real‐world evidence for pharmacovigilance and drug safety‐related decision making by a resource‐limited health authority: 10 years of experience in Taiwan

  2020cites this paper
• Antibiotic prescribing and non-prescribing in nursing home residents with signs and symptoms ascribed to urinary tract infection (ANNA): study protocol for a cluster randomized controlled trial

  2020cites this paper
• Effects of low intraperitoneal pressure on quality of postoperative recovery after laparoscopic surgery for genital prolapse in elderly patients age 75 years and older.

  2020cites this paper
• Complex and Potentially Harmful Medication Patterns in Heart Failure with Preserved Ejection Fraction.

  2020cites this paper
• How polypharmacy affects frailty

  2020cites this paper